RG
RegeneRx Biopharmaceuticals, Inc.
RGRX · OTC
$0.00 +0.00% (+$0.00)
1M +57.14%
Market Cap $898.0
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Moderate
4/9Valuation
100 /100
Cheap P/S 0.01x
EV/FFO N/A
P/E N/A
Growth
20 /100
Declining Rev. growth 0.00%
Book val. growth N/A
EPS growth N/A
Profitability
20 /100
Weak Op. margin 1,826.45%
Gross margin 100.00%
FCF margin 1,225.52%
Quality
61 /100
Average Asset turnover 0.20x
ROIC 1,654.75%
ROA 451.89%
Debt
52 /100
Moderate Net debt/EBITDA -0.82x
Current ratio 0.55x
Int. coverage -4.31x
Stability
31 /100
Unstable EPS volatility 4,091.19%
Beta 4.73x
Profitable years 0
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o RGRX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
J. J. Finkelstein
Employees
2
Headquarters
Rockville